Cargando…

Biological effects of HBV X protein on hepatocellular carcinogenesis in association with cellular factors

The X protein (HBx) of Human hepatitis B virus (HBV) acts as an indirect transcriptional transactivator to regulate the expression of many viral and cellular genes, as well as playing a critical role in pathogenesis and the development of Hepatocellular carcinoma (HCC). Here we described the biologi...

Descripción completa

Detalles Bibliográficos
Autores principales:	Wang, Shi-qun, Wu, Jian-guo
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	SP Wuhan Institute of Virology, CAS 2008
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7090866/ http://dx.doi.org/10.1007/s12250-008-2952-9

Ejemplares similares

Effects of antiviral therapy on post-hepatectomy HBV reactivation and liver function in HBV DNA-negative patients with HBV-related hepatocellular carcinoma
por: Gong, Wen-Feng, et al.
Publicado: (2017)

Constructing the HBV-human protein interaction network to understand the relationship between HBV and hepatocellular carcinoma
por: Wu, Zhong-Jun, et al.
Publicado: (2010)

Current Molecular Biology and Therapeutic Strategy Status and Prospects for circRNAs in HBV-Associated Hepatocellular Carcinoma
por: Liao, Rui, et al.
Publicado: (2021)

Hepatitis B virus whole-X and X protein play distinct roles in HBV-related hepatocellular carcinoma progression
por: Zhang, Yu, et al.
Publicado: (2016)

The Role of Antiviral Therapy for HBV-Related Hepatocellular Carcinoma
por: Yu, Liang-He, et al.
Publicado: (2011)

The Mechanisms of HBV-Induced Hepatocellular Carcinoma
por: Jiang, Yu, et al.
Publicado: (2021)

Association of TIP30 expression and prognosis of hepatocellular carcinoma in patients with HBV infection
por: Zhang, Xia, et al.
Publicado: (2016)

Reduced HBV cccDNA and HBsAg in HBV-associated hepatocellular carcinoma tissues
por: Tantiwetrueangdet, Anchalee, et al.
Publicado: (2018)

Association of HBV DNA replication with antiviral treatment outcomes in the patients with early-stage HBV-related hepatocellular carcinoma undergoing curative resection
por: Chen, Jian-Lin, et al.
Publicado: (2016)

HBV X protein mutations affect HBV transcription and association of histone-modifying enzymes with covalently closed circular DNA
por: Chong, Chun Kong, et al.
Publicado: (2020)

Advances in Multi-Omics Applications in HBV-Associated Hepatocellular Carcinoma
por: Cui, Dawei, et al.
Publicado: (2021)

In situ analysis of hepatitis B virus (HBV) antigen and DNA in HBV-induced hepatocellular carcinoma
por: Zheng, Ye, et al.
Publicado: (2022)

Bioinformatics analysis of the proteins interacting with LASP-1 and their association with HBV-related hepatocellular carcinoma
por: Kong, Fan-Yun, et al.
Publicado: (2017)

HBV X Protein Induces Degradation of UBXN7, a Novel Negative Regulator of NF-κB Signaling, to Promote HBV Replication
por: Yuan, Sen, et al.
Publicado: (2022)

Serum LncRNAs Profiles Serve as Novel Potential Biomarkers for the Diagnosis of HBV-Positive Hepatocellular Carcinoma
por: Wang, Kang, et al.
Publicado: (2015)

Genomic and oncogenic preference of HBV integration in hepatocellular carcinoma
por: Zhao, Ling-Hao, et al.
Publicado: (2016)

HBV-DNA Load-Related Peritumoral Inflammation and ALBI Scores Predict HBV Associated Hepatocellular Carcinoma Prognosis after Curative Resection
por: Liao, Rui, et al.
Publicado: (2018)

Translational Regulation in Hepatocellular Carcinogenesis
por: Bracic Tomazic, Suzana, et al.
Publicado: (2021)

HBV X protein-based therapeutic vaccine accelerates viral antigen clearance by mobilizing monocyte infiltration into the liver in HBV carrier mice
por: Horng, Jau-Hau, et al.
Publicado: (2020)

Compartmentalisation of Hepatitis B virus X gene evolution in hepatocellular carcinoma microenvironment and the genotype-phenotype correlation of tumorigenicity in HBV-related patients with hepatocellular carcinoma
por: Fu, Ya, et al.
Publicado: (2022)

High mobility group AT-hook 1 (HMGA1) is an important positive regulator of hepatitis B virus (HBV) that is reciprocally upregulated by HBV X protein
por: Shen, Zhongliang, et al.
Publicado: (2022)

Biology of Radiation Carcinogenesis
por: Hendry, J. H., et al.
Publicado: (1976)

Biology of radiation carcinogenesis
por: Yuhas, John M, et al.
Publicado: (1976)

HBV integrated genomic characterization revealed hepatocyte genomic alterations in HBV-related hepatocellular carcinomas
por: Yang, Ming, et al.
Publicado: (2020)

The Intracellular HBV DNAs as Novel and Sensitive Biomarkers for the Clinical Diagnosis of Occult HBV Infection in HBeAg Negative Hepatocellular Carcinoma in China
por: Wang, Hui, et al.
Publicado: (2014)

Clinicopathological Criteria for Multicentricity of Hepatocellular Carcinoma and Risk Factors for Such Carcinogenesis
por: Kubo, Shoji, et al.
Publicado: (1998)

Prostatic carcinogenesis evoked by cellular interaction.
por: Chung, L W, et al.
Publicado: (1988)

Prognostic significance of catalase expression and its regulatory effects on hepatitis B virus X protein (HBx) in HBV-related advanced hepatocellular carcinomas
por: Cho, Mi-Young, et al.
Publicado: (2014)

Update Treatment for HBV Infection and Persistent Risk for Hepatocellular Carcinoma: Prospect for an HBV Cure
por: Yoo, Joseph, et al.
Publicado: (2018)

Hepatitis B virus (HBV) X gene mutations and their association with liver disease progression in HBV-infected patients
por: Al-Qahtani, Ahmed A., et al.
Publicado: (2017)

Erratum: Genomic and oncogenic preference of HBV integration in hepatocellular carcinoma
por: Zhao, Ling-Hao, et al.
Publicado: (2016)

HBV genome-enriched single cell sequencing revealed heterogeneity in HBV-driven hepatocellular carcinoma (HCC)
por: Wang, Wenhui, et al.
Publicado: (2022)

Early Alpha-Fetoprotein Response Is Associated With Survival in Patients With HBV-Related Hepatocellular Carcinoma Receiving Lenvatinib
por: Liu, Bo, et al.
Publicado: (2022)

Concerns about the inverse relationship between baseline HBV DNA and on-treatment hepatocellular carcinoma risk
por: Liu, Shi, et al.
Publicado: (2022)

Effects of transarterial chemoembolization combined with antiviral therapy on HBV reactivation and liver function in HBV-related hepatocellular carcinoma patients with HBV-DNA negative
por: Wang, Kai, et al.
Publicado: (2018)

The Biological Function of Hepatitis B Virus X Protein in Hepatocellular Carcinoma
por: Xu, Qiaodong, et al.
Publicado: (2019)

Serum Iron Levels Decreased in Patients with HBV-Related Hepatocellular Carcinoma, as a Risk Factor for the Prognosis of HBV-Related HCC
por: Wei, Yanyan, et al.
Publicado: (2018)

Association of CD44 polymorphisms and susceptibility to HBV‐related hepatocellular carcinoma in the Chinese population
por: Deng, Yan, et al.
Publicado: (2019)

Bioinformatics analysis reveals meaningful markers and outcome predictors in HBV-associated hepatocellular carcinoma
por: Zhang, Lijie, et al.
Publicado: (2020)

Profiling of Exome Mutations Associated with Progression of HBV-Related Hepatocellular Carcinoma
por: Woo, Hyun Goo, et al.
Publicado: (2014)

Cannot write session to /tmp/vufind_sessions/sess_i11vi1a1af0qq017tmgk97dps0